Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1314987-79-5

Tert-butyl3-(4-nitro-1H-pyrazol-1-yl)azetidine-1-carboxylate is a synthetic organic compound with the chemical formula C12H20N4O4. It belongs to the class of azetidine carboxylates and features a nitro group and pyrazole ring in its structure. This versatile chemical is known for its potential pharmacological properties, including anti-inflammatory and analgesic effects, and is commonly used as a building block in the synthesis of pharmaceuticals and agrochemicals due to its reactivity and functional groups. The presence of the tert-butyl group in its structure provides stability and steric hindrance, making it a valuable intermediate in organic synthesis.

1314987-79-5 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 1314987-79-5 Structure

  • Basic information

    1. Product Name: tert-butyl3-(4-nitro-1H-pyrazol-1-yl)azetidine-1-carboxylate
    2. Synonyms: tert-butyl3-(4-nitro-1H-pyrazol-1-yl)azetidine-1-carboxylate
    3. CAS NO:1314987-79-5
    4. Molecular Formula: C11H16N4O4
    5. Molecular Weight: 268.26914
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 1314987-79-5.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: 2-8°C
    8. Solubility: N/A
    9. CAS DataBase Reference: tert-butyl3-(4-nitro-1H-pyrazol-1-yl)azetidine-1-carboxylate(CAS DataBase Reference)
    10. NIST Chemistry Reference: tert-butyl3-(4-nitro-1H-pyrazol-1-yl)azetidine-1-carboxylate(1314987-79-5)
    11. EPA Substance Registry System: tert-butyl3-(4-nitro-1H-pyrazol-1-yl)azetidine-1-carboxylate(1314987-79-5)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 1314987-79-5(Hazardous Substances Data)

1314987-79-5 Usage

Uses

Used in Pharmaceutical Industry:
Tert-butyl3-(4-nitro-1H-pyrazol-1-yl)azetidine-1-carboxylate is used as a building block for the synthesis of pharmaceuticals due to its versatile reactivity and functional groups. Its potential pharmacological properties, such as anti-inflammatory and analgesic effects, make it a promising candidate for drug discovery and development.
Used in Agrochemical Industry:
In the agrochemical industry, tert-butyl3-(4-nitro-1H-pyrazol-1-yl)azetidine-1-carboxylate is utilized as a building block for the synthesis of agrochemicals, taking advantage of its reactivity and functional groups to create effective compounds for agricultural applications.
Used in Organic Synthesis:
Tert-butyl3-(4-nitro-1H-pyrazol-1-yl)azetidine-1-carboxylate is used as a valuable intermediate in organic synthesis, where its tert-butyl group provides stability and steric hindrance, facilitating the creation of complex organic molecules for various applications.

Check Digit Verification of cas no

The CAS Registry Mumber 1314987-79-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,1,4,9,8 and 7 respectively; the second part has 2 digits, 7 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1314987-79:
(9*1)+(8*3)+(7*1)+(6*4)+(5*9)+(4*8)+(3*7)+(2*7)+(1*9)=185
185 % 10 = 5
So 1314987-79-5 is a valid CAS Registry Number.

1314987-79-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name tert-butyl 3-(4-nitro-1H-pyrazol-1-yl)azetidine-1-carboxylate

1.2 Other means of identification

Product number -
Other names tert-butyl3-(4-nitro-1H-pyrazol-1-yl)azetidine-1-carboxylate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1314987-79-5 SDS

1314987-79-5Downstream Products

1314987-79-5Relevant articles and documents

FGFR Inhibitor compounds and uses thereof

-

Paragraph 0487; 0490; 0492-0494, (2021/11/21)

The invention relates to FGFR inhibitor compounds and uses thereof. , The application discloses a compound as shown in a formula (I). A compound, or an optical isomer, a geometric isomer, a tautomer or isomer mixture thereof, or a pharmaceutically acceptable salt thereof, or a prodrug thereof, or a metabolite thereof. The application further relates to the application of the compound in medicine.

ATF6 MODULATORS AND USES THEREOF

-

Paragraph 254, (2021/04/17)

Compounds (1-2) as modulators of Activating Transcription Factor 6 (ATF6) are provided. The compounds may find use as therapeutic agents for the treatment of diseases or disorders mediated by ATF6 and may find particular use in the treatment of viral infections, neurodegenerative diseases, vascular diseases, or cancer. (Formula (1-2))

INHIBITORS OF NECROPTOSIS

-

Page/Page column 37; 38, (2021/09/04)

This invention relates to compounds of Formula (I) and salts, solvates, prodrugs, tautomers, N-oxides, stereoisomers, polymorphs and physiologically functional derivatives thereof. Also disclosed are methods of use of Formula (I), including in the inhibition of necroptosis and treatment of associated diseases, conditions and/or disorders.

PYRROLO(PYRAZOLO)PYRIMIDINE DERIVATIVE AS LRRK2 INHIBITOR

-

, (2020/11/23)

The present invention relates to a pyrrolo(pyrazolo)pyrimidine derivative having efficacy as an LRRK2 inhibitor, a preparation method therefor, and a pharmaceutical composition for preventing or treating degenerative brain diseases, containing the same.

BENZAMIDES OF PYRAZOLYL-AMINO-PYRIMIDINYL DERIVATIVES, AND COMPOSITIONS AND METHODS THEREOF

-

Paragraph 00362, (2020/07/07)

Provided is a novel class of orally and/or topically available, selective and potent JAK inhibitors as safe and effective therapeutics against various diseases and disorders. More particularly, provided are pharmaceutical composition of these compounds and methods of their preparation and use thereof.

BMP-SIGNAL-INHIBITING COMPOUND

-

Paragraph 0587, (2019/11/19)

The present invention relates to novel and excellent small-molecule-corn pounds that specifically antagonize BMP signal pathways, and these compounds can be used to modulate cell growth, differentiation, proliferation, and apoptosis, and thus can be used to treat diseases or pathological symptoms related to BMP signal pathway including inflammation, cardiovascular diseases, hematopoietic diseases, cancer, osteodystrophia, or the like, particularly, fibrodysplasia ossificans progressiva, and the present invention relates to provision of a pharmaceutical and pharmacological agent used for specifically antagonizing the BMP signal pathways and acting on the BMP signal pathways in the prevention and treatment or experimental application since the compounds can be beneficial for regulating cell differentiation and/or cell proliferation.

Five-And-Six-Membered Heterocyclic Compound, And Preparation Method, Pharmaceutical Composition And Use Thereof

-

Paragraph 0353; 0356, (2015/12/07)

A five-and-six-membered heterocyclic compound as represented by general formula I, pharmaceutically acceptable salt, metabolite, metabolic precursors or drug precursors thereof, preparation method, pharmaceutical composition, and use thereof; the five-and-six-membered heterocyclic compound has activity as a Janus kinase (JAK) inhibitor, and can be used to prepare drugs for treating diseases caused by the abnormal activity of kinase, such as cell proliferation diseases like cancer.

BIARYL COMPOUNDS USEFUL FOR THE TREATMENT OF HUMAN DISEASES IN ONCOLOGY, NEUROLOGY AND IMMUNOLOGY

-

Paragraph 0229, (2015/06/25)

The present invention provides compounds and compositions thereof which are useful as inhibitors of Bruton's tyrosine kinase and which exhibit desirable characteristics for the same.

HETEROCYCLIC COMPOUND

-

Paragraph 0520, (2015/03/03)

The present invention provides an agent for the prophylaxis or treatment of autoimmune diseases (e.g., psoriasis, rheumatoid arthritis, inflammatory bowel disease, Sjogren's syndrome, Behcet's disease, multiple sclerosis, systemic lupus erythematosus etc.) and the like, which has a superior Tyk2 inhibitory action. The present invention relates to a compound represented by the formula wherein each symbol is as defined in the specification, or a salt thereof.

A practical, two-step synthesis of 1-alkyl-4-aminopyrazoles

Zabierek, Anna A.,Konrad, Kaleen M.,Haidle, Andrew M.

, p. 2996 - 2998 (2008/09/20)

A novel synthesis of N1 alkyl-substituted pyrazoles with a free amino group at the C4 position is described. Commercially available 4-nitropyrazole was found to readily undergo Mitsunobu reactions with primary and secondary alcohols. Subsequent reduction of the nitro group via hydrogenation affords 1-alkyl-4-aminopyrazoles, which are valuable intermediates in the synthesis of pharmaceutically active compounds.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1314987-79-5